All Stories

  1. SARS-CoV-2 Vaccine Mandates for Patients on the Kidney Transplant Waitlist
  2. Short-term antibody response and tolerability after one dose of BNT162b2 vaccine in patients receiving hemodialysis: A report from the Quebec Renal Network COVID-19 study
  3. Quality of Life and Hemodynamic Effects of Switching From Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort Study
  4. Re-Envisioning the Canadian Nephrology Trials Network: A Can-SOLVE-CKD Stakeholder Meeting of Patient Partners and Researchers
  5. Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study
  6. COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter
  7. Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team
  8. Proceedings From a Canadian Nephrology Forum: Nephrology Is Back
  9. Use of the FRAIL Questionnaire in Patients With End-Stage Kidney Disease
  10. Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials
  11. The Author Replies:
  12. The Authors Reply
  13. Hypertension in pregnancy afterEscherichia coliO157:H7 gastroenteritis: a cohort study
  14. Canadian Society of Nephrology Guidelines for the Management of Patients With ESRD Treated With Intensive Hemodialysis
  15. Dialysate Calcium Concentration and Mineral Metabolism in Long and Long-Frequent Hemodialysis: A Systematic Review and Meta-analysis for a Canadian Society of Nephrology Clinical Practice Guideline
  16. Vascular Access for Intensive Maintenance Hemodialysis: A Systematic Review for a Canadian Society of Nephrology Clinical Practice Guideline
  17. Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium
  18. Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis
  19. Risk of Vascular Access Complications with Frequent Hemodialysis
  20. A multinational cohort study of in-center daily hemodialysis and patient survival
  21. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials
  22. Case report: Atenolol overdose successfully treated with hemodialysis
  23. Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis
  24. Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis
  25. Early dialysis
  26. Patient experiences and preferences on short daily and nocturnal home hemodialysis
  27. Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis
  28. Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis
  29. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
  30. Urine Volume and Change in Estimated GFR in a Community-Based Cohort Study
  31. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada
  32. Dipstick Proteinuria as a Screening Strategy to Identify Rapid Renal Decline
  33. Peritoneal dialysis vs hemodialysis: time to end the debate?
  34. Hemodialysis in a Satellite Unit: Clinical Performance Target Attainment and Health-Related Quality of Life
  35. Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials
  36. Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011
  37. Design and Rationale of Health-Related Quality of Life and Patient-Reported Outcomes Assessment in the Frequent Hemodialysis Network Trials
  38. International quotidian dialysis registry: Annual report 2010
  39. Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study
  40. Opioid and Benzodiazepine Use in End-Stage Renal Disease: A Systematic Review
  41. Recruitment and Training for Home Hemodialysis: Experience and Lessons from the Nocturnal Dialysis Trial
  42. Risk of Pregnancy-Related Hypertension Within 5 Years of Exposure to Drinking Water Contaminated With Escherichia coli O157:H7
  43. Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription
  44. International quotidian dialysis registry: Annual report 2009
  45. Factors that led to the Walkerton tragedy
  46. Relationship between Escherichia coli O157:H7 and diabetes mellitus
  47. Renal prognosis of toxigenic Escherichia coli infection
  48. Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water
  49. TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials
  50. PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Frequent Hemodialysis and Psychosocial Function
  51. Elevated Blood Pressure in Relation to Overweight and Obesity Among Children in a Rural Canadian Community
  52. The International Quotidian Dialysis Registry: Annual report 2008
  53. The International Quotidian Hemodialysis Registry: Rationale and challenges
  54. Can Extracellular Fluid Volume Expansion in Hemodialysis Patients Be Safely Reduced Using the Hemocontrol Biofeedback Algorithm? A Randomized Trial
  55. Albuminuria and Estimated GFR 5 Years After Escherichia coli O157 Hemolytic Uremic Syndrome: An Update
  56. Excessive fluid intake as a novel cause of proteinuria
  57. The International Quotidian Dialysis Registry: Annual Report 2007
  58. Frequent Hemodialysis Network (FHN) randomized trials: Study design
  59. The International Quotidian Dialysis Registry: Annual report 2006
  60. Randomized Trials of Frequent Hemodialysis – Infinite Possibilities
  61. Diabetes in Diarrhea-Associated Hemolytic Uremic Syndrome: A Systematic Review and Meta-Analysis
  62. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water
  63. The International Quotidian Dialysis Registry: Annual report 2005
  64. Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination
  65. Is more frequent hemodialysis beneficial and what is the evidence?
  66. The International Quotidian Hemodialysis Registry: Rationale and methods
  67. Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome
  68. Adequacy of quotidian hemodialysis
  69. The impact of quotidian hemodialysis on nutrition
  70. Volume control and blood pressure management in patients undergoing quotidian hemodialysis